Branch, D. R. (2018). ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis. American Society of Hematology (ASH).
Chicago Style (17th ed.) CitationBranch, D. R. ABO Zygosity, but Not Secretor or Fc Receptor Status, Is a Significant Risk Factor for IVIG-associated Hemolysis. American Society of Hematology (ASH), 2018.
MLA (9th ed.) CitationBranch, D. R. ABO Zygosity, but Not Secretor or Fc Receptor Status, Is a Significant Risk Factor for IVIG-associated Hemolysis. American Society of Hematology (ASH), 2018.
Warning: These citations may not always be 100% accurate.